| 31. |
List of subsidiaries are
as follows: |
| |
|
Date of |
|
Place of |
|
|
|
|
| Name of Company |
|
acquisition |
|
incorporation |
|
Effective interest |
|
Principal activities |
|
|
|
|
|
|
2025 |
|
2024 |
|
|
| |
|
|
|
|
|
% |
|
% |
|
|
| Alps
Global Holding Berhad |
|
June 11, 2024 |
|
Malaysia |
|
100 |
|
- |
|
Investment holding company |
| |
|
|
|
|
|
|
|
|
|
|
| Held through Alps Global Holding Berhad: |
| |
| Alps
Biotech Sdn. Bhd. |
|
May 9, 2019 |
|
Malaysia |
|
95 |
|
95 |
|
Investment advisory services, leasing of intellectual property and research and development on medical sciences |
| |
|
|
|
|
|
|
|
|
|
|
|
Alpscap Berhad
|
|
April 11, 2018 |
|
Malaysia |
|
51 |
|
51 |
|
Investment holding |
| |
|
|
|
|
|
|
|
|
|
|
|
Alps
Wellness Centre Sdn. Bhd.
|
|
March 31, 2021 |
|
Malaysia |
|
100 |
|
100 |
|
Business of health screening, beauty aesthetics and to act as wellness centre |
| |
|
|
|
|
|
|
|
|
|
|
| Celestialab Sdn. Bhd. |
|
February 7, 2018 |
|
Malaysia |
|
100 |
|
100 |
|
Medical research, cultivating and manufacturing stem cells |
| |
|
|
|
|
|
|
|
|
|
|
| Celebre Pro Medic Sdn. Bhd. |
|
July 15, 2020 |
|
Malaysia |
|
100 |
|
100 |
|
Business of beauty, healthcare consultancy and therapist |
| |
|
|
|
|
|
|
|
|
|
|
| Mont Life (M) Sdn. Bhd. |
|
July 6, 2020 |
|
Malaysia |
|
100 |
|
100 |
|
Provision of consultancy services in relation to healthcare, beauty and aesthetics specialties |
| |
|
|
|
|
|
|
|
|
|
|
| Mygenome Sdn. Bhd. |
|
November 27, 2018 |
|
Malaysia |
|
99 |
|
99 |
|
Research and development on biotechnology, provide medical testing and laboratory services, and manufacture and sales of medical medicaments |
| |
|
|
|
|
|
|
|
|
|
|
|
TMC Global Holdings Sdn. Bhd.
|
|
July 15, 2020 |
|
Malaysia |
|
100 |
|
100 |
|
Beauty and health care consultants |
| |
|
|
|
|
|
|
|
|
|
|
| Alps
Insurance PCC INC |
|
April 10, 2024 |
|
Labuan |
|
51 |
|
51 |
|
Licensed Labuan insurance captive |
On
11 June 2024, the Company acquired 53%
of the voting shares of Alps Global Holding Berhad. Subsequently, on 4 July 2024, the Company acquired an additional 46%,
and on 24 July 2024, it acquired a further 1%.
|